Metraipolis › archive › dc_4be46cc36608
The power and the promise of epigenetic drugs in oncology — Europe PMC PMID:41551874
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41551874
- DOI
- 10.3389/fgene.2025.1622115
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T02:52:02.400Z
- SHA-256 of the archived text
3eb1ec5fd55d31c919fe0a9315924cd5903d9b109dc2d559022f1ce64915b861- Stable URL of this page
https://metraipolis.com/documento/dc_4be46cc36608
How to cite
The power and the promise of epigenetic drugs in oncology — Europe PMC PMID:41551874 — Europe PMC (en), https://europepmc.org/article/MED/41551874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4be46cc36608 (Metraipolis archive dc_4be46cc36608, sha256 3eb1ec5fd55d31c919fe0a9315924cd5903d9b109dc2d559022f1ce64915b861)
BibTeX
@misc{dc4be46cc36608,
title = {The power and the promise of epigenetic drugs in oncology — Europe PMC PMID:41551874},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41551874},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4be46cc36608; sha256 3eb1ec5fd55d31c919fe0a9315924cd5903d9b109dc2d559022f1ce64915b861},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41551874. Agents can read the archived copy with the MCP tool read_document.